175 related articles for article (PubMed ID: 18184860)
1. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis.
Eitner F; Bücher E; van Roeyen C; Kunter U; Rong S; Seikrit C; Villa L; Boor P; Fredriksson L; Bäckström G; Eriksson U; Ostman A; Floege J; Ostendorf T
J Am Soc Nephrol; 2008 Feb; 19(2):281-9. PubMed ID: 18184860
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis.
Martin IV; Borkham-Kamphorst E; Zok S; van Roeyen CR; Eriksson U; Boor P; Hittatiya K; Fischer HP; Wasmuth HE; Weiskirchen R; Eitner F; Floege J; Ostendorf T
Am J Pathol; 2013 Jan; 182(1):107-17. PubMed ID: 23141925
[TBL] [Abstract][Full Text] [Related]
3. Complement C5 mediates experimental tubulointerstitial fibrosis.
Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
[TBL] [Abstract][Full Text] [Related]
4. Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis.
Boor P; Bábíčková J; Steegh F; Hautvast P; Martin IV; Djudjaj S; Nakagawa T; Ehling J; Gremse F; Bücher E; Eriksson U; van Roeyen CR; Eitner F; Lammers T; Floege J; Peutz-Kootstra CJ; Ostendorf T
Am J Pathol; 2015 Aug; 185(8):2132-42. PubMed ID: 26216283
[TBL] [Abstract][Full Text] [Related]
5. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury.
Taneda S; Hudkins KL; Topouzis S; Gilbertson DG; Ophascharoensuk V; Truong L; Johnson RJ; Alpers CE
J Am Soc Nephrol; 2003 Oct; 14(10):2544-55. PubMed ID: 14514732
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
7. PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.
Hou X; Kumar A; Lee C; Wang B; Arjunan P; Dong L; Maminishkis A; Tang Z; Li Y; Zhang F; Zhang SZ; Wardega P; Chakrabarty S; Liu B; Wu Z; Colosi P; Fariss RN; Lennartsson J; Nussenblatt R; Gutkind JS; Cao Y; Li X
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12216-21. PubMed ID: 20566880
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family.
Reigstad LJ; Varhaug JE; Lillehaug JR
FEBS J; 2005 Nov; 272(22):5723-41. PubMed ID: 16279938
[TBL] [Abstract][Full Text] [Related]
9. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
Crawford Y; Kasman I; Yu L; Zhong C; Wu X; Modrusan Z; Kaminker J; Ferrara N
Cancer Cell; 2009 Jan; 15(1):21-34. PubMed ID: 19111878
[TBL] [Abstract][Full Text] [Related]
10. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
11. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy.
Nishida M; Okumura Y; Sato H; Hamaoka K
Nephrol Dial Transplant; 2008 Aug; 23(8):2520-4. PubMed ID: 18515792
[TBL] [Abstract][Full Text] [Related]
12. The role of PDGF-D in healthy and fibrotic kidneys.
Buhl EM; Djudjaj S; Babickova J; Klinkhammer BM; Folestad E; Borkham-Kamphorst E; Weiskirchen R; Hudkins K; Alpers CE; Eriksson U; Floege J; Boor P
Kidney Int; 2016 Apr; 89(4):848-61. PubMed ID: 26924050
[TBL] [Abstract][Full Text] [Related]
13. Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.
van Roeyen CRC; Martin IV; Drescher A; Schuett KA; Hermert D; Raffetseder U; Otten S; Buhl EM; Braun GS; Kuppe C; Liehn E; Boor P; Weiskirchen R; Eriksson U; Gross O; Eitner F; Floege J; Ostendorf T
Kidney Int; 2019 May; 95(5):1103-1119. PubMed ID: 30827511
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury.
Furuichi K; Gao JL; Murphy PM
Am J Pathol; 2006 Aug; 169(2):372-87. PubMed ID: 16877340
[TBL] [Abstract][Full Text] [Related]
15. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies.
Platt JL; Ferguson RM; Sibley RK; Gajl-Peczalska KJ; Michael AF
Transplantation; 1983 Sep; 36(3):343-6. PubMed ID: 6351377
[No Abstract] [Full Text] [Related]
16. Role of PDGF in fibrotic diseases and systemic sclerosis.
Trojanowska M
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v2-4. PubMed ID: 18784131
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune pancreatitis: expression and cellular source of profibrotic cytokines and their receptors.
Detlefsen S; Sipos B; Zhao J; Drewes AM; Klöppel G
Am J Surg Pathol; 2008 Jul; 32(7):986-95. PubMed ID: 18460977
[TBL] [Abstract][Full Text] [Related]
18. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
Murray LA; Argentieri RL; Farrell FX; Bracht M; Sheng H; Whitaker B; Beck H; Tsui P; Cochlin K; Evanoff HL; Hogaboam CM; Das AM
Int J Biochem Cell Biol; 2008; 40(10):2174-82. PubMed ID: 18395486
[TBL] [Abstract][Full Text] [Related]
19. Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis.
Zhuo Y; Zhang J; Laboy M; Lasky JA
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L182-8. PubMed ID: 12972405
[TBL] [Abstract][Full Text] [Related]
20. Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C.
Zhao J; Liu Z; Liu T; Nilsson S; Nistér M
Exp Cell Res; 2008 Aug; 314(14):2529-43. PubMed ID: 18588873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
